Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jun 24;17(6):e86691.
doi: 10.7759/cureus.86691. eCollection 2025 Jun.

Analgesic Efficacy of Remifentanil Versus Dexmedetomidine in Patients Undergoing Bariatric and Metabolic Surgeries: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Abhijit Nair  1 , Tuhin Mistry  2 , Hosam Elghadban  3 , Chetan Shende  4 , Nitinkumar Borkar  5 , Ahmed Elzayyat  6
Affiliations
Review

Analgesic Efficacy of Remifentanil Versus Dexmedetomidine in Patients Undergoing Bariatric and Metabolic Surgeries: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Abhijit Nair et al. Cureus. .

Abstract

Obese patients undergoing bariatric and metabolic surgeries require tailored perioperative pain management. This review aimed to compare the analgesic efficacy and safety of two adjuncts used in general anesthesia (GA), remifentanil and dexmedetomidine, in this patient population. Using relevant keywords, we searched PubMed, Scopus, the Cochrane Library, and ClinicalTrials.gov, identifying five randomized controlled trials for a qualitative systematic review and quantitative meta-analysis. The RoB 2 tool was used to assess the risk of bias, and the meta-analysis was conducted using RevMan version 5.4. The Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach was employed to evaluate the overall quality of evidence. Trial Sequential Analysis (TSA) was used to confirm significant findings. The overall risk of bias was low, and the GRADE quality ranged from moderate to low. Twenty-four-hour opioid consumption and pain scores in the recovery room were comparable between the two groups (mean difference (MD): 0.23; 95% CI: -1.42 to 1.89, P = 0.78; and MD: 0.04; 95% CI: -0.48 to 0.57, P = 0.87, respectively). Postoperative nausea and vomiting (PONV) was significantly lower in the dexmedetomidine group (OR: 2.55; 95% CI: 1.60 to 4.07, P < 0.0001), a finding confirmed by TSA. However, the cumulative sample size represented only 82.5% of the required information size. Overall heterogeneity was low to moderate. Based on the findings of this review, analgesic efficacy, measured by 24-hour opioid consumption and recovery room pain scores, appears comparable between remifentanil and dexmedetomidine. However, the incidence of PONV was significantly lower in the dexmedetomidine group. Further studies are warranted to identify the most suitable adjunct to GA in this high-risk patient population.

Keywords: `anesthesia; bariatric & metabolic surgery; peri-operative analgesia; remifentanil; dexmedetomidine.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Figures

Figure 1
Figure 1. PRISMA flow diagram.
PRISMA: Preferred Reporting Items for Systematic Reviews and Meta-Analyses.
Figure 2
Figure 2. A: Traffic light plot; B: Summary plot.
Figure 3
Figure 3. A: Forest plot comparing 24-hour opioid consumption; B: Forest plot comparing PONV; C: Forest plot comparing pain scores in the recovery room.
PONV: Postoperative nausea/vomiting.
Figure 4
Figure 4. A: Forest plot comparing surgery duration between the two groups; B: Forest plot comparing anesthesia duration between the two groups.
Figure 5
Figure 5. Trial sequential analysis comparing PONV between the two groups.
PONV: Postoperative nausea/vomiting.
See this image and copyright information in PMC

Similar articles

See all similar articles

References

    1. Anesthetic implications of obesity in the surgical patient. Dority J, Hassan ZU, Chau D. Clin Colon Rectal Surg. 2011;24:222–228. - PMC - PubMed
    1. The patient with obesity and super-super obesity: perioperative anesthetic considerations. Kaye AD, Lingle BD, Brothers JC, Rodriguez JR, Morris AG, Greeson EM, Cornett EM. Saudi J Anaesth. 2022;16:332–338. - PMC - PubMed
    1. Anesthesia for morbidly obese patients. Hardt K, Wappler F. Dtsch Arztebl Int. 2023;120:779–785. - PMC - PubMed
    1. Dexmedetomidine in current anaesthesia practice-a review. Naaz S, Ozair E. J Clin Diagn Res. 2014;8:0. - PMC - PubMed
    1. Systematic assessment of dexmedetomidine as an anesthetic agent: a meta-analysis of randomized controlled trials. Piao G, Wu J. Arch Med Sci. 2014;10:19–24. - PMC - PubMed

LinkOut - more resources